PetersJ.Breast cancer genetics: relevance to oncology practice. Cancer Cont: JMCC.1995; 2: 195–208.
2.
ArnessonL.G., SmedsS., FagerbergG.Recurrence-free survival in patients with small breast cancers: an analysis of cancers 10 mm or less detected clinically and by screening. Eur J Surg.1994; 160: 271–276.
3.
FracchiaA.A., RobinsonD., LegaspiA.Survival in bilateral breast cancer. Cancer.1985; 55: 1414–1421.
4.
RobbinsG.F., BergJ.W.: Bilateral primary breast cancers: a prospective clinicopathological study. Cancer.1964; 17: 1501–1527.
5.
McCredieJ.A., InchW.R., AldersonM.Consecutive primary carcinomas of the breast. Cancer.1975; 35: 1472–1477.
6.
DawsonP.J., MaloneyT., GimottyP.Bilateral breast cancer: one disease or two?Breast Cancer Res Treat.1991; 19: 233–244.
7.
PriorP., WaterhouseJ.A.The incidence of bilateral breast cancer: II. a proposed model for the analysis of coincidental tumours. Br J Cancer.1981; 43: 615–622.
8.
RingbergA., PalmerB., LinellF.Bilateral and multifocal breast carcinoma: a clinical and autopsy study with special emphasis on carcinoma in situ. Eur J Surg Oncol.1991; 17: 20–29.
9.
CadyB.Familial bilateral cancer of the breast. Ann Surg.1970; 172: 264–272.
10.
AndersonD.E., BadziochM.D.Bilaterality in familial breast cancer patients. Cancer.1985; 56: 2092–2098.
11.
HolmbergL., AdamiH.O., EkbomA.Prognosis in bilateral breast cancer: effects of time interval between first and second primary tumours. Br J Cancer.1988; 58, 191–194.
12.
KhafagyM.M., SchottenfeldD., RobbinsG.F.Prognosis of the second breast cancer: the role of previous exposure to the first primary. Cancer.1975; 35: 596–599.
13.
GrahamM.D., YellandA., PeacockJ.Bilateral carcinoma of the breast. Eur J Surg Oncol.1993; 19: 259–264.
14.
RobinsonE., RennertG., RennertH.S.Survival of first and second primary breast cancer. Cancer.1993; 71: 172–176.
15.
BrennerH., EngelsmannB., StegmaierC.Clinical epidemiology of bilateral breast cancer. Cancer.1993; 72: 3629–3635.
16.
LidereauR., SoussiT.Absence of p53 germ-line mutations in bilateral breast cancer patients. Hum Genet.1992; 89: 250–252.
17.
AckermanJ., BaunochD.A., GimottyP.The role of p53 mutations in bilateral breast carcinoma. Mod Pathol.1995; 8: 244–248.
18.
SpitalierJ.M., GambarelliJ., BrandoneH.Breast-conserving surgery with radiation therapy for operable mammary carcinoma: a 25-year experience. World J Surg.1986; 10: 1014–1020.
19.
RechtA., SchnittS.J., ConnollyJ.L.Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. Int J Radiat Oncol Biol Phys.1989; 16: 3–9.
20.
HafftyB.G., FischerD., BeinfieldM.Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys1991; 21: 293–298.
21.
DawsonP.J.: What is new in our understanding of multifocal breast cancer. Pathol Res Pract.1993; 189: 111–116.
22.
FisherE.R., GregorioR., RedmondC.Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4): I. observations concerning the multicentricity of mammary cancer. Cancer.1975; 35: 247–254.
23.
LesserM.L., RosenP.P., KinneD.W.Multicentricity and bilaterality in invasive breast carcinoma. Surgery.1982; 91: 234–240.
24.
EganR.L.Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer.1982; 49: 1123–1130.
25.
SchwartzG.F., PatchesfskyA.S., FeigS.A.Multicentricity of non-palpable breast cancer. Cancer.1980; 45: 2913–2916.
26.
TinnemansJ.G., WobbesT., van der SluisR.F.Multicentricity in nonpalpable breast carcinoma and its implications for treatment. Am J Surg.1986; 151: 334–338.
27.
GallagerH.S., MartinJ.E.The study of mammary carcinoma by mammography and whole organ sectioning: early observations. Cancer.1969; 23: 855–873.
28.
DawsonP.J., BaekeyP.A., ClarkR.A.Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol.1995; 26: 965–969.
29.
DavidoffA.M., KernsB.J., IglehartJ.D.Maintenance of p53 alterations throughout breast cancer progression. Cancer Res.1991; 51: 2605–2610.
30.
IglehartJ.D., KrausM.H., LangtonB.C.Increased erb B-2 gene copies and expression in multiple stages of breast cancer. Cancer Res.1990; 50: 6701–6707.
31.
EstebanJ.M., BattiforaH.Tumor immunophenotype: comparison between primary neoplasm and its metastases. Mod Pathol.1990; 3: 192–197.
32.
EnbladP., GlimeliusB., BuschC.Antigenic heterogeneity and individuality in adenocarcinomas of the rectum and their secondaries. Br J Cancer.1987; 55: 503–508.
33.
VogelsteinB., FearonE.R., HamiltonS.R.Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science.1985; 227: 642–645.
34.
NoguchiS., AiharaT., KoyamaH.Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis. Cancer.1994; 74: 872–877.
35.
TeixeiraM.R., PandisN., BardiG.Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal similarities between tumour foci. Br J Cancer.1994; 70: 922–927.
36.
TsudaH., HirohashiS.Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q. Cancer Res.1995; 55: 3395–3398.
37.
RosenP.P., SenieR., SchottenfeldD.Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg.1979; 189: 377–382.
38.
LagiosM.D., MargolinF.R., WestdahlP.R.Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer.1989; 63: 618–624.
39.
SilversteinM.J., CohlanB.F., GiersonE.D.Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer.1992; 28:
40.
SchwartzG.F., FinkelG.C., GarciaJ.C.Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone. Cancer.1992; 70: 2468–2474.
41.
KinneD.W., PetrekJ.A., OsborneM.P.Breast carcinoma in situ. Arch Surg.1989; 124: 33–36.
42.
SchwartzG.F., PatchefskyA.S., FinklesteinS.D.Nonpalpable in situ ductal carcinoma of the breast. Arch Surg.1989; 124: 29–32.
43.
NoguchiS., MotomuraK., InajiH.Clonal analysis of predominantly intraductal carcinoma and precancerous lesions of the breast by means of polymerase chain reaction. Cancer Res.1994; 54: 1849–1853.
44.
TavassoliF.A.Pathology of the Breast.Norwalk, Conn: Appleton & Lange; 1992: 263–291.
45.
PageD.L., KiddT.E.Jr, DupontW.D.Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol.1991; 22: 1232–1239.
46.
HaagensenC.D., LaneN., BodianC.Coexisting lobular neoplasia and carcinoma of the breast. Cancer.1983; 51: 1468–1482.
47.
SunshineJ.A., MoseleyH.S., FletcherW.S.Breast carcinoma in situ: a retrospective review of 112 cases with a minimum 10 year follow-up. Am J Surg.1985; 150: 44–51.
48.
UrbanJ.A.Bilaterality of cancer of the breast: biopsy of the opposite breast. Cancer.1967; 20: 1867–1870.
49.
CarsonW., Sanchez-ForgachE., StomperP.Lobular carcinoma in-situ: observation without surgery as an appropriate therapy. Ann Surg Oncol.1994; 1: 141–146.
50.
WebberB.L., HeiseH., NeifeldJ.P.Risk of subsequent contralateral breast carcinoma in a population of patients with insitu breast carcinoma. Cancer.1981; 47:
51.
CataliottiL., DistanteV., CiattoS.Intraductal breast cancer: review of 183 consecutive cases. Eur J Cancer.1992; 28A: 917–920.
52.
TempleW.J., JenkinsM., AlexanderF.Natural history of in situ breast cancer in a defined population. Ann Surg.1989; 210:
